[HTML][HTML] New developments in osteoarthritis and cartilage biology

B Poulet, KA Staines - Current opinion in pharmacology, 2016 - Elsevier
Highlights•Osteoarthritis (OA) is a common and debilitating disease with no effective
treatments.•Articular chondrocyte behavior and matrix maintenance are major targets.•The …

Emerging targets in osteoarthritis therapy

MB Goldring, F Berenbaum - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Different OA etiologies present a challenge for developing a single targeted
therapy.•Common mechanisms occur in inflammatory, mechanical, and oxidative stress in …

From osteoarthritis treatments to future regenerative therapies for cartilage

J Clouet, C Vinatier, C Merceron, M Pot-vaucel… - Drug discovery today, 2009 - Elsevier
Osteoarthritis (OA) is associated with cartilage degeneration and an accompanying
inflammatory syndrome of the synovium in addition to alteration of the subchondral bone …

Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis

JR Kim, JJ Yoo, HA Kim - International journal of molecular sciences, 2018 - mdpi.com
Osteoarthritis (OA) is the most prevalent joint disease in older people and is characterized
by the progressive destruction of articular cartilage, synovial inflammation, changes in …

Current advances in therapies for osteoarthritis

KC Kalunian - Current Opinion in Rheumatology, 2016 - journals.lww.com
Current advances in therapies for osteoarthritis : Current Opinion in Rheumatology Current
advances in therapies for osteoarthritis : Current Opinion in Rheumatology Log in or Register …

[HTML][HTML] OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?

MPH Le Graverand-Gastineau - Osteoarthritis and cartilage, 2009 - Elsevier
OBJECTIVE: The purpose of this article is to review the current status of drug development
as it relates to both molecular targets and clinical trials for osteoarthritis (OA). METHODS: A …

[HTML][HTML] An up to date on clinical prospects and management of osteoarthritis

M Maqbool, G Fekadu, X Jiang, F Bekele… - Annals of Medicine and …, 2021 - Elsevier
The rising prevalence of osteoarthritis (OA) in the general population has necessitated the
development of novel treatment options. It is critical to recognize the joint as a separate …

[PDF][PDF] Future directions for research and treatment of osteoarthritis

CJ Malemud, VM Goldberg - Front Biosci, 1999 - article.imrpress.com
[Frontiers in Bioscience 4, d762-771, October 15, 1999] 762 FUTURE DIRECTIONS FOR
RESEARCH AND TREATMENT OF OSTEOARTHRITIS Charl Page 1 [Frontiers in Bioscience 4 …

The future of osteoarthritis therapeutics: emerging biological therapy

A Mobasheri - Current rheumatology reports, 2013 - Springer
Biological therapy is a thriving area of research and development, and is well established for
chronic forms of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). However, there is …

Emerging pharmaceutical therapies for osteoarthritis

A Latourte, M Kloppenburg, P Richette - Nature Reviews Rheumatology, 2020 - nature.com
The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …